DE000HG9ACS3/ DE000HG9ACS3 /
2024-05-13 9:35:16 PM | Chg.+0.040 | Bid9:41:33 PM | Ask9:41:33 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
4.340EUR | +0.93% | 4.340 Bid Size: 10,000 |
4.570 Ask Size: 10,000 |
GRAND CITY PROPERT.E... | 6.5904 EUR | 2078-12-31 | Call |
GlobeNewswire
12:56 AM
Rumble Files Second Lawsuit Against Google for Monopolistic and Anticompetitive Practices
GlobeNewswire
05-13
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Seritage Growt...
GlobeNewswire
05-13
Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
GlobeNewswire
05-13
Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
05-13
DealFlow Events Selects IBN as an Official Media Partner of the Reg A and Crowdfunding Conference 20...
GlobeNewswire
05-13
Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Se...
GlobeNewswire
05-13
Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial...
GlobeNewswire
05-13
Madison Realty Capital and Unity Capital Originate $100 Million Construction Loan for Mixed-Use Mult...
GlobeNewswire
05-13
Bitdeer Reports Unaudited Financial Results for the First Quarter of 2024 and Operational Update
GlobeNewswire
05-13
Great Pacific Gold Reports Multiple High-Grade Gold Assays from Kesar Creek Project in Papua New Gui...
GlobeNewswire
05-13
IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Present...
GlobeNewswire
05-13
Pan American Energy Commences the Spring 2024 Field Prospecting and Sampling Program At The Big Mack...
GlobeNewswire
05-13
GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-13
Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update